Skip to content
Home
Visit our other Journals
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Specialties
Hematology
Oncology
Musculoskeletal Disorder
Rare Disease
Metabolic Disorder
Cardiovascular Disease
Ophthalmology
Neurology
Infectious Disease
View all Specialties
Technologies
Cell Therapy
MSC
iPSC
Gene Therapy
Genome Editing
Extracellular Vesicles
CAR-T Therapy
TCR Therapy
Tissue-Engineering & Biomaterials
View all Technologies
Topics
Treatment
Immuno-Oncology
Trial Updates
Perspectives
Manufacturing
COVID-19
View all Topics
Conferences
ASH 2022
TCT 2022
Meeting on the Med 2022
ICLE 2022
Advanced Therapies Week 2022
TERMIS 2021
ESGCT 2021
Meeting on the Mesa 2021
Advanced Therapies 2021
View all Conferences
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Neurology
2:26
Nerve regeneration with polyhydroxyalkanoate-based conduits
Ipsita Roy
• 11 Nov 2021
1:28
Researching the impact of innervation on regenerating tissues
Paul Wieringa
• 18 Nov 2021
2:03
Research barriers in neural engineering
Paul Wieringa
• 18 Nov 2021
4:07
The role of stem cells in treating CNS disorders
Anne des Rieux
• 25 Nov 2021
1:58
Delivering drugs to the CNS with extracellular vesicles
Anne des Rieux
• 25 Nov 2021
4:49
Neural stem cells isolated from the CSF for a potential autologous cell therapy
Beatriz Fernández-Muñoz
• 25 Jun 2021
2:44
Challenges with translating gene therapies for neurodevelopmental disorders
Ralf Schmid
• 16 Nov 2021
2:56
Non-viral gene delivery & gene editing: highlights from ESGCT
Ralf Schmid
• 16 Nov 2021
8:51
Eladocagene exuparvovec: AAV2-mediated gene therapy for AADC deficiency
Paul Wuh-Liang Hwu
• 17 Nov 2021
6:19
LYS-GM101 AAV gene therapy for GM1 gangliosidosis
Michael Hocquemiller
• 15 Nov 2021
3:49
The gene-replacement therapy landscape for CDKL5-deficiency disorder
Ralf Schmid
• 16 Nov 2021
4:23
AAV9-mediated gene therapy for CDKL5-deficiency disorder
Ralf Schmid
• 16 Nov 2021
2:38
LYS-SAF302 AAV gene therapy for MPS IIIA
Michael Hocquemiller
• 15 Nov 2021
1:48
ESGCT 2021 highlights: AAV vector capsid modification for CNS disorders
Michael Hocquemiller
• 15 Nov 2021
1:14
Applications of brain organoids in neurology
Ira Espuny-Camacho
• 9 Nov 2021
3:59
ATA3219, ATA3271 & ATA188: T-Cell immunotherapy products in development
Pascal Touchon
• 22 Oct 2021
1
2
3
Next